A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 24
- Registration Number
- NCT00938262
A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 15
- Registration Number
- NCT00938132
A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT00938197
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)
Phase 2
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2009-07-13
- Last Posted Date
- 2009-07-13
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 81
- Registration Number
- NCT00937651
A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers
Phase 1
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2009-06-18
- Last Posted Date
- 2009-10-08
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 34
- Registration Number
- NCT00923533
Antihypertensive Efficacy and Tolerability and Determine the Adequate Antihypertensive Dosage of Fimasartan in Mild to Moderate Essential Hypertension Patients
- First Posted Date
- 2009-06-18
- Last Posted Date
- 2009-06-18
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 182
- Registration Number
- NCT00923611
- Locations
- 🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
Clinical Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan in Hypertension Patients
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 506
- Registration Number
- NCT00922480
A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension
Phase 2
Completed
- Conditions
- Essential Hypertension
- Interventions
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 92
- Registration Number
- NCT00922441
Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients
Phase 4
Completed
- Conditions
- Well-controlled Hypertension
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2010-12-15
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 191
- Registration Number
- NCT00386529
- Locations
- 🇰🇷
Kyungpook National University Hospital, Daegu, Korea, Republic of
Cilnidipine Effect on High Blood Pressure and Cerebral Perfusion in Ischemic Stroke Patients With Hypertension
- First Posted Date
- 2006-05-15
- Last Posted Date
- 2008-12-12
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 250
- Registration Number
- NCT00325637
- Locations
- 🇰🇷
Seoul National University Budang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath